Archive for February 2025
SeptiCyte RAPID performance is not affected by different sites of primary infection in sepsis – Poster
SeptiCyte RAPID performance is not affected by different sites of primary infection in sepsis Roy F. Davis, MD, PhD, MHA Chief Medical Officer, Immunexpress Inc. Seattle, WA
Read MoreDiagnosing Pediatric Sepsis With SeptiCyte® RAPID Host Gene Expression — Poster
Diagnosing Pediatric Sepsis With SeptiCyte® RAPID Host Gene Expression Jerry J Zimmerman, MD, PhD, MCCM Abstract Submission Number: 1885548 on behalf of the Pediatric SeptiCyte® RAPID Investigators
Read MoreImmunexpress to Present New Data at the Society of Critical Care Medicine (SCCM) 2025 Critical Care Congress
SEATTLE and BRISBANE, Australia, Feb. 24, 2025 /PRNewswire/ — Immunexpress, Pty Ltd., a molecular diagnostic company focused on improving outcomes for suspected sepsis patients, today announced its participation, including the presentation of two posters, at the Society of Critical Care Medicine (SCCM) 2025 Critical Care Congress in Orlando, Florida, from February 23 – 25, 2025.…
Read More